These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3090427)

  • 21. Lipoprotein(a), atherosclerosis, and apolipoprotein(a) gene polymorphism.
    Pati U; Pati N
    Mol Genet Metab; 2000; 71(1-2):87-92. PubMed ID: 11001801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA polymorphisms flanking insulin gene and atherosclerosis.
    Jowett NI; Rees A; Caplin J; Williams LG; Galton DJ
    Lancet; 1984 Aug; 2(8398):348. PubMed ID: 6146887
    [No Abstract]   [Full Text] [Related]  

  • 23. DNA markers in the hyperlipidaemias and atherosclerosis.
    Rees A
    J R Coll Physicians Lond; 1987 Jan; 21(1):51-4. PubMed ID: 3469405
    [No Abstract]   [Full Text] [Related]  

  • 24. [Genes in atherosclerosis].
    Brdicka R
    Cas Lek Cesk; 1988 Nov; 127(48):1482-5. PubMed ID: 2907418
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic determinants of atherosclerosis-related dyslipidemias and their clinical implications.
    Galton DJ
    Clin Chim Acta; 1997 Jan; 257(2):181-97. PubMed ID: 9118562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic-epidemiological studies of apolipoprotein(a) polymorphism and its significance in nephrological diseases and type I diabetes mellitus].
    Kronenberg F; Auinger M; Dieplinger H
    Acta Med Austriaca; 1999; 26(5):142-7. PubMed ID: 11512190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA sequences flanking the insulin gene on chromosome 11 confer risk of atherosclerosis.
    Mandrup-Poulsen T; Owerbach D; Mortensen SA; Johansen K; Meinertz H; Sørensen H; Nerup J
    Lancet; 1984 Feb; 1(8371):250-2. PubMed ID: 6142996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular patho-biochemistry and genetic diagnosis for plasminogen-apolipoprotein (a) gene family related to atherosclerosis and thrombosis].
    Ichinose A
    Rinsho Byori; 1998 Dec; 46(12):1210-8. PubMed ID: 9916506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ApaI RFLP 5.4 kb 5' to the human apolipoprotein AI (APO A1) gene.
    Frossard PM; Coleman R; Funke H; Assman G
    Nucleic Acids Res; 1986 Feb; 14(4):1922. PubMed ID: 3005987
    [No Abstract]   [Full Text] [Related]  

  • 30. Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians.
    Davignon J; Bouthillier D; Nestruck AC; Sing CF
    Trans Am Clin Climatol Assoc; 1988; 99():100-10. PubMed ID: 3503432
    [No Abstract]   [Full Text] [Related]  

  • 31. Linkage and segregation analyses of apolipoproteins A1 and B, and lipoprotein cholesterol levels in a large pedigree with excess coronary heart disease: the Bogalusa Heart Study.
    Amos CI; Elston RC; Srinivasan SR; Wilson AF; Cresanta JL; Ward LJ; Berenson GS
    Genet Epidemiol; 1987; 4(2):115-28. PubMed ID: 3108069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of polymorphisms for apolipoprotein B (ins/del, XbaI, EcoRI) and apolipoprotein E on serum lipids and apolipoproteins in a Javanese population.
    Gajra B; Candlish JK; Saha N; Heng CK; Soemantri AG; Tay JS
    Genet Epidemiol; 1994; 11(1):19-27. PubMed ID: 8013886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rare and common mutations in hyperlipidemia and atherosclerosis. With special reference to familial defective apolipoprotein B-100.
    Tybjaerg-Hansen A
    Scand J Clin Lab Invest Suppl; 1995; 220():57-76. PubMed ID: 7652481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SstI RFLP and hypertension as risk factors for extracoronary atherosclerosis in a male population of southern Italy.
    Pujia A; Gnasso A; Siclari D; Dominijanni A; Zingone A; Marasco O; Mele E; Cortese C; Colonna A; Mattioli PL
    Artery; 1994; 21(4):208-21. PubMed ID: 8830647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular biology of apolipoproteins in genesis of hyperlipidemias and atherosclerosis].
    Hata Y
    Nihon Rinsho; 1993 Jun; 51(6):1668-76. PubMed ID: 8320847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linkage heterogeneity between the C3 and LDLR and the APOA4 and APOA1 loci in baboons.
    Kammerer CM; Hixson JE; Aivaliotis MJ; Porter PA; VandeBerg JL
    Genomics; 1992 Sep; 14(1):43-8. PubMed ID: 1427832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible association between DNA sequences flanking the insulin gene and atherosclerosis.
    Owerbach D; Johansen K; Billesbølle P; Poulsen S; Schroll M; Nerup J
    Lancet; 1982 Dec; 2(8311):1291-3. PubMed ID: 6128593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The identification of polymorphisms in the coding region of the apolipoprotein (a) gene--association with earlier identified polymorphic sites and influence on the lipoprotein (a) concentration.
    Prins J; Leus FR; Bouma BN; van Rijn HJ
    Thromb Haemost; 1999 Dec; 82(6):1709-17. PubMed ID: 10613659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein (a): genetic marker for atherosclerosis?
    Breckenridge WC
    CMAJ; 1990 Jul; 143(2):115. PubMed ID: 2364334
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic variants of the lipoproteins and hyperlipidaemia.
    Galton DJ; Stocks J; Rees A
    Biochem Soc Trans; 1985 Feb; 13(1):31-4. PubMed ID: 3922820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.